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Fresh serum opsonizes certain microorganisms, conferring upon them the
property of being recognized and rapidly ingested by phagocytes (1) . Studies in
several laboratories during the past decade have established that erythrocytes,
bacteria, and other particles can be opsonized by the sequential reactions of
antibody and classical complement (C) components C1, C4, C2, and C3 or by the
properdin system and C3 (2-10) . In either case, the fixation ofC3 insome form to
the surface of the particles seems to be critical for rapid ingestion by phagocytes
(3,10) . Erythrocytes or bacteria opsonized by C action subsequently lose
ingestibility when incubated for prolonged intervals in serum (2,8) . One enzyme
of the blood, the C3b inactivator (or conglutinogen-activating factor (KAF]')
which attacks C3 bound to erythrocytes, has been isolated from the serum of
various species (11-15) and is capable of modifying the opsonic expression of
bound C3 (2) .
No information exists concerning the molecular nature of the C3-derived
product that confers opsonic expression . C3 is an incompletely characterized and
multifunctional molecule which when activated by the classical or by the
properdin pathways liberates an anaphylatoxic fragment, Ma, while the rest of
the molecule, C3b, is somehow involved in the activation of the terminal C
molecules, C5-C9, and acts as a cofactor in the properdin system (16,17) . C3b is
cleaved by the C3b inactivator to yield a product, CM, which is no longer
capable of activating the properdin pathway . C3b' is sensitive to various
proteolytic enzymes which further degrade the molecule to C3c (18, 19) . Two
other fragments, called C3c and Cad, appear during activation of C3 (16, 20) .
Their detailed structures and biological significance are unknown .
Analysis of opsonically active C3 requires an approach which provides for a
strict correlation between the structure of bound C3 and its opsonic expression .
We have demonstrated that the initial rate of ingestion by human peripheral
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blood phagocytes of paraffin oil droplets containing Oil red 0 and stabilized with
bacterial lipopolysaccharide (LPS) or with human serum albumin (HSA)
increases as C3 is deposited from fresh serum onto thesurfaces ofthe particles (9,
10) . The properdin system mediates the deposition .
This report describes the effect of various physical and chemical agents and of
proteolytic enzymes on the ingestibility and bound radioactivity of LPS- and
HSA-coated particles opsonized with fresh serum containing [1251]C3 . Ingestibil-
ity and bound radioactive C3 on the particles resisted treatment with strong
dissociating agents . Therefore, it was possible to undertake immunochemical and
structural analysis of opsonized particles after removal of many contaminating
serum proteins . The findings indicated that opsonically active C3 is a molecule
composed oftwo 70,000 mol wt subunits linked by disulfide bonds . Reduction and
alkylation of these linkages impairs opsonic function as does alkylation of
reactive sulfhydryl groups on the molecule . Comparison of the opsonically active
fragment of C3 with purified C3 indicated that one of the 70,000 mol wt
polypeptides is also a 70,000 mol wt subunit of intact C3 ; and that the other is a
fragment of a 115,000 mol wt heavy chain in intact C3 . Summaries of this work
have been published (21, 22) .
Materials and Methods
LPS andHSA .
￿
LPS prepared by the procedure of Westphal andJann (23) from Escherichia coli
026:B6 or else Salmonella enteritidis was purchasedfrom Difco Laboratories, Detroit, Mich . The LPS
as received, when dissolved in 1% sodium dodecyl sulfate, 8M urea, and 2-mercaptoethanol solution
sometimes revealed bands of variable molecular weights after electrophoresis on polyacrylamide gels .
Attempts to diminish the protein content of the LPS by additional cycles of extraction with
phenol-water (23) were effective, but repurified LPS with low protein content or prepared by
phenol-water extraction from E. coli 026:B6 (acquired from the American Type Cell Culture
Collection, Rockville, Md .) had identical properties to the crude commercial LPS in the biological
system under study . ["C]LPS with a sp act of 4.63 pCi/mg, prepared from S. enteritidis grown in
[14C ]glucose, was a gift from Dr . Jon Rudbach of the University of Montana, Missoula, Mont . HSA
was purchased from Nutritional Biochemicals Corporation, Cleveland, Ohio .
LPS- and HSA-Coated Particles .
￿
Heavy paraffin oil containing Oil red 0 was emulsified with
LPS suspended in modified Krebs-Ringer phosphate medium (KRPM: 119mM NaCl, 4.8 mM KCI,
0.9 mM CaCl 1 .2 mM MgCl,, and9.3 mM sodium phosphate buffer, pH 7 .4) at a concentration of 10
mg/ml or emulsified with HSA dissolved in modified KRPM at a concentration of 20 mg/ml, as
previously described (9, 10). Oil red0was dissolved in the paraffin oil by mixing 5 g of the dye with 50
ml of oil in a mortar with a pestle . The solution was centrifuged at 20,000g for 30 min to remove
undissolved dye. The process was repeated, mixing the oil with dye that sedimented during
centrifugation .By this technique, 0.01 ml of Oil red0 in paraffin oil diluted to 10 ml with p-dioxane
had an absorbance of 0.4-0 .9 at 525 nm whichwashigher than that achieved with methods previously
described (9, 10) . Forexperiments in which ingestion rates ofthe particles were not correlated with C3
binding or elution, particles were prepared with fluorochemical liquid (Minnesota Mining &
Manufacturing Co ., St. Paul, Minn .) as previously described (10) . Because of the higher density
of these particles (1.74), washing was accomplished more easily than with the paraffin oil particles .
The biological properties of HSA-coated fluorochemical particles with respect to recognition by
phagocytes before and after exposure to serum were previously shown to correlate with those of
HSA-coated paraffin oil particles (10) . ["C]LPS-coated particleswere prepared by adding 5.26 juCi of
["C]LPS from S . enteritidis to 30 mg of carrier S. enteritidis LPS, and the mixture was used to
emulsify paraffin oil . The final particle preparation had a specific radioactivity of 2.44 uCi/ml of
particle suspension . All particles were washed twice with modified KRPM to remove LPS in free
suspension or HSA in solution after emulsification . Paraffin oil particles were centrifuged at 20,000 g
for 10 min, and infranatant solutions were removedfrom the particle pellicles . Coated fluorochemicalSTOSSEL, FIELD, GITLIN, ALPER, AND ROSEN
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particles were centrifuged at 100g for 5 min, and supernatant fluids were removedbetween washes .
The particles were finally suspended in modified KRPM such that 1 ml of fluorochemical liquid or
paraffin oil was contained in 3 ml of aqueous medium .
Reaction of Coated Particles with Serum plus ["°I]C3 (Opsonization) .
￿
Purified human C3 (24)
labeled with ""I (sp act 1-5 x 10' cpm/gg) (25) was added to serum prepared from freshly drawn
human blood or stored at -70°C (fresh serum) or to serum heated for 30 min at 56°C (heated serum)
to yield a final sp act of 10'-10° cpm/ml of serum . The C3 concentration offreshserum samples was
determined by an automatednephelometric method (26) . Suspensions of coated particles were added
to equal volumes of fresh or heated serum plus ["SI]C3, the amounts of particles and serum being
determined by thevolumes of particles required fora given experiment . In time-course experiments,
particles and sera were heated to 37°C before mixing . Samples were removed at zero time and at
intervals thereafter, and cooled immediately by being added to 15 volumes of ice-cold solutions of
bovine serum albumin, 20 mg/ml in 0.15MNaCl (albumin solution) .The particles were washed twice
in albumin solution and then twice in 0.13MNaCI-20mM sodium phosphate buffer, pH 7.4 (isotonic
buffer) . Particles treated as described were designated "opsonized washed particles."
Reaction of Opsonized Washed Particles with Various Reagents .
￿
Opsonized washed fluorochemi-
cal liquid particle pellets or paraffin oil particle pellicles were suspended in five volumes of solutions
containing test agents andincubated at concentrations andtimes described in the Results section . Of
the test materials, NaCl, glucose, MgCl,, sodium metaperiodate, guanidine, urea, Triton X-100,
Brij-35, EDTA, deoxycholate, sodium dodecyl sulfate, sodium decyl sulfate, 2-mercaptoethanol,
chloroform, and butanol were reagent-grade chemicals . Phospholipase A and phospholipase C were
purchased from Calbiochem, San Diego, Calif., and trypsin from Worthington Biochemical Corp.,
Freehold,N.J . KAF-deficient humanserumwasobtained from a patient with genetically determined
total deficiency of that enzyme (27) . Purified KAF was generously provided by Dr . Peter Lachmann .
Anti-C3 F(ab'), fragments were prepared by pepsin digestion of goat antihuman C3 (28) . Particles
reacted with the test substances were subsequently washed twice with isotonic buffer and once with
distilled water.
Preparation of Particles for Elution.
￿
Of packed, washed, opsonized LPS-coated or HSA-coated
particles, 1ml was suspended in 5 ml of 2MNaCl and boiled for 15 min.The particles were packed by
centrifugation, washed once with deionized distilled water, and packed again . The emulsions were
broken by addition of 5 ml of n-butanol and centrifuged at 40,000 g for 20 min . The butanol was
evaporated under a stream of nitrogen, and the paraffin oil or fluorocarbon removed by aspiration .
The dried residue, containing about 6,000 cpm of '"I radioactivity, was suspended in 0.3 ml of a
solution containing 2% sodium dodecyl sulfate, 1% 2-mercaptoethanol (or 50mM dithiothreitol), 8M
urea, 0.01 mg/ml eosin Y, 100 mg/ml sucrose, and 20 mM Tris-HCI buffer of pH 7 .0 (gel sample
solution), and incubated for 1 h at 37°C . Dithiothreitol or 2-mercaptoethanol were omitted from
solutions used for preparation of unreduced eluates . Some eluates of opsonized washed LPS-coated
particles contained material that precipitated during electrophoresis on polyacrylamide gels with
dodecyl sulfate . This material, whichwas not identified, wasremoved when eluates were passed over
1 x 60 cm columns of Sephadex G-100 equilibrated with dodecyl sulfate, 2-mercaptoethanol, and 20
mM Tris-acetate buffer of pH 7 .0 . The radioactive peaks eluted yielded the same results when
subjected to electrophoresis on polyacrylamide gels with dodecyl sulfate as did eluates for which gel
filtration was not required .
Alkylation of Opsonized Washed Particles .
￿
Ofopsonized, washed, packed paraffin oil particles, 1
ml was suspended in 3 ml of 0.03mM iodoacetic acid and incubated at 25°C for 30 min .The particles
were washed five times with isotonic buffer and prepared for assessment of ingestibility and '2°I
radioactivity as described below . Control alkylation experiments were performed by adding
iodoacetic acid at the end of the 30-min incubation to ensure that any detrimental effects of
iodoacetate on ingestibility were not due to toxicity exerted by residual-free iodoacetate against test
cells . Reductionand alkylation of particles were performedby incubating opsonized, washed paraffin
oil particles with 0.025 mM 2-mercaptoethanol for 15 min at 25°C before adding the iodoacetate .
C3 Fragments and Subunits .
￿
C3b was prepared by brief tryptic digestion of C3 (29) . The C3
fragments C3c and Cad were isolated from aged human serum and identified by their electrophoretic
mobilities in agarose gels and reactivities with anti-C3(A determinant) andanti-a,D .C3 and ["SIIC3
were denatured by boiling for 15 min in 1% dodecyl sulfate, 2-mercaptoethanol (or 50 mM dithiotrei-
tol), 8Murea, and 20mM Tris-acetate buffer ofpH 7.0. Approximately 100 ug of denatured protein1332 THE OPSONIC FRAGMENT OF C3
and 5,000-10,000 cpm were applied to polyacrylamide gels and electrophoresed as described below .
Peptides in the gels were located by scanning at 280 nm with a Gilford spectrophotometer (Gilford
Instrument Laboratories, Inc ., Oberlin, Ohio) with a scanning and recording device, and protein-con-
taining portions of the gels were eluted overnight with a solution of dodecyl sulfate . In other
experiments, 2 mg of denatured C3 plus 2-5 x 10' cpm Of [125I]C3 were applied to 102x 0.8 cm col-
ums of Sephadex G-100 and eluted with a solution containing 1 M proprionic acid, 6 M urea, 0.5%
dodecyl sulfate, and 1% 2-mercaptoethanol . [I'll ]C3 was also chromatographed on a 2 x 89 cm column
of Bio-RadA15M (Bio-Rad Laboratories, Richmond, Calif), 200-400 mesh (4% agarose), equilibrated
and eluted with 0.6 M KCl and 20 mM Tris-maleate buffer ofpH 7.0 . Eluted column or gel fractions
were assayed for 1'.I radioactivity, concentrated by vacuum dialysis, and analyzed for purity by poly-
acrylamide gel electrophoresis in dodecyl sulfate .
Antisera .
￿
Opsonized, washed, LPS-coated fluorochemical particles were washed with 2M NaCl,
boiled for 15 min, and washed and suspended in sterile distilled water . Samples of 0.1 ml were
injected every other day for a total ofseven injections into rabbits . Injections were repeated thereafter
at monthly intervals, and bloodsamples were taken 1 wk after the last monthly injection . Antisera to
C3 and C3d were generated in rabbits . The antiserum to C3 reacted in immunoelectrophoresis only
with native C3, C3b, and C3c but not C3d . The antiserum to C3d reacted with native C3, C3b, and
Cad but not C3c .
Analytical Procedures
ASSAY OF INGESTIBILITY . Opsonized, washed paraffin oil particles or particles exposed to other
reagents were suspended in modified KRPM such that 0.3 ml ofparaffin oilwassuspended in 1 ml . Of
the particle suspension, 0.2 ml was added to 2-6 x 10'human peripheral blood leukocytes in 0.8 ml of
modified KRPM . The leukocytes, prepared as described (28), were composed of70-90% "phagocytes"
(neutrophils plus monocytes) . The initial rate of ingestion of the paraffin oil particles by the phago-
cytes was spectrophotometrically assayed as previously described (9, 10, 30) .
ASSAY OF RADIOACTIVITY .
￿
I'll of labeled C3, of serum to which radioactive C3 was added, of
opsonized washed particles, of samples eluted from Sephadex columns, and of slices cut from
polyacrylamide gels was measured directly with an autogamma spectrometer (Packard Instrument
Co ., Inc ., DownersGrove, Ill .) . Samples (0 .2 ml) of ["C ]LPS, of opsonized washed particles prepared
with ["C]LPS, and of ["C]LPS were dissolved in 0.8 ml of Protosol (New England Nuclear, Boston,
Mass .) overnight at 25 °C. The digested samples were neutralized with 0.25 ml of glacial acetic acid
and added to 10 ml of Aquasol (New England Nuclear) . Radioactivity of the samples in the
scintillation fluid was determined with a Packard scintillation spectrometer (Packard Instrument
Co ., Inc.) . Polyacrylamide gel slices containing "C were dissolved in 0.2 ml of 30% hydrogen peroxide
before addition of Protosol .
POLYACRYLAMIDE GEL ELECTROPHORESIS . Samples for electrophoresis were dissolved (gel sample
buffer), boiled for 15 min, centrifuged for 5 min in a Beckman microcentrifuge apparatus (Beckman
Instruments, Inc ., Fullerton, Calif.), and applied in 40 to 80-ul quantities to 5% polyacrylamide gels
with 0.13% cross-linker . The electrophoresic procedure was that of Fairbanks et al . (31) . After
electrophoresis, the gels were stained with Coomassie Brilliant Blue and destained with 10% acetic
acid in a Hoefer destaining apparatus (Hoefer Scientific Instruments, San Francisco, Calif.) or else
frozen and cut into 2-mm slices with a razor blade . Some gels were treated with periodic acid-Schiff
(PAS) stain (32) . The molecular weights of unknown proteins were determined by comparing their
mobilities with those of known molecular weights including rabbit muscle myosin (33), beta-galac-
tosidase (Sigma Chemical Co ., St . Louis, Mo .), bovine serum albumin (Nutritional Biochemicals
Corporation), rabbit muscle actin (34), chymotrypsinogen A, ovalbumin, and cytochrome C
(Worthington Biochemical Corp .) .
IMMUNOCHEMICAL ANALYSIS .
￿
Reactions of antisera with purified proteins were analyzed by double
diffusion in agar gel and by immunoelectrophoresis (35) .
TRYPTIC PEPTIDE MAPS .
￿
Of [" 51]C3, 0.2 ug was heated in a boiling water bath for 40 min, reduced
and alkylated with 2.5 mM dithiothreitol and 5mM ethyleneimine, dialyzed against distilled water,
and lyophilized. The residue was dissolved in 5 ml of0.1M ammonium bicarbonate containing trypsin,
0.02 Ag/kg of C3, and was incubated for 14 h at 37°C . Thesample was repeatedly lyophilized with 5%
acetic acid and finally dissolved in distilled water at aconcentration of50 gg/ml . Of the sample, 20 Al
were electrophoresed on Whatman 3M paper for 38 min at 3,000 V in water :pyridine :acetic acid,STOSSEL, FIELD, GITLIN, ALPER, AND ROSEN
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90.6 :9 .1:0 .3, pH 6.5 . Chromatography was performed in the descending direction in butanol:acetic
acid:pyridine :water, 37.5 :7.5:25:30 . The maps were stained with ninhydrin or else autoradiographed
with Kodak Royal X-Omat RP/R54 X-ray film (Eastman Kodak Co ., Rochester, N. Y.) . C3
fragments were eluted from polyacrylamide gels by incubating gel slices in 0.05% sodium dodecyl
sulfate, 5mM sodium bicarbonate at 37°C for 12 h. The procedure was repeated twice and thethree
eluates were pooled andconcentrated to 1-ml vol in collodion sacs undervacuum . After reduction and
alkylation, the sampleswere dialyzed against three changes of 1 liter of absolute methanol to remove
thedodecyl sulfate . The samples were dialyzed against distilled water, lyophilized, anddigested with
trypsin as described above.
Results
Ingestibility and Bound C3 Radioactivity of LPS-Coated Particles
CORRELATION DURING INCUBATION IN FRESH SERUM. Human neutrophils in-
gested LPS-coated paraffin oil particles at a very slow rate, but this rate was
markedly accelerated by prior incubation of the particles in fresh human serum
containing [125I]C3 at 37°C,and they bound radioactivity (Fig. 1) . The increase in
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FIG . 1 . Ingestibility and bound C3 radioactivity of LPS-coated paraffin oil particles .
Particles were incubated with serum containing ["SI)C3 at 37°C . At the indicated times,
samples were removed, washed, andtested forbound radioactivity and ingestibilitybyhuman
blood phagocytes .
ingestibility and radioactivity of the particles with time of incubation in serum
correlated precisely, and both properties were maximal at 25-30 min of
incubation . When serum-treated LPS-coated particles were washed with isotonic
buffer and incubated a second time with fresh serum containing ["'I]C3, the
ingestion rate and bound radioactivity increased by 25% at most, indicating that
the maximal opsonic expression and uptake of radioactivity reflected saturation
of available sites on the particles rather than depletion of reagents in the serum
required for deposition of C3 .
However, decay of opsonic expression and of radioactivity was in part
responsible for the lack of a greater increment during incubation of the particles
in serum . As shown in Fig . 1, radioactivity and ingestibility decreased in parallel
at a constant rate for at least 90 min after maximal activity and radioactivity
were achieved ; the rate of decline in activity was slower than the rate of
opsonization and binding of radioactivity . The disappearance of radioactivity
and loss of ingestibility from the particles occurred in serum, in heated serum,1334
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and in serum containing 1 mM EDTA, but not in buffer (Table I). The rate of
decay of radioactivity was diminished but not abolished by treatment of the
serum with 3 mM sodium m-periodate, an inhibitor of KAF, or by employing
serum totally lacking KAF activity. Purified KAF and trypsin removed radio-
activity and diminished the ingestibilityofparticles. Phospholipases Aand C had
no effect on either property.
EFFECTS OF PHYSICAL AND CHEMICAL AGENTS .
￿
The particles retained ingestibility
and radioactivity after being washed in isotonic buffer and albuminsolutions. To
determine the stability of opsonically active C3, particles were maximally
opsonized (for 30 min) in fresh serum containing ["'I]C3, washed with isotonic
buffer and albumin, and then exposed to the treatmentssummarized in Table II.
Extremes of ionic strength and of pH, various dissociating agents, repeated
freezing and thawing, sonication, certain nonionic orionic detergents either alone
or in combination, and even with boiling caused less than 25% of bound
radioactivity and less than 15% of ingestibility to be lost from the serum-treated
particles. Treatment of unopsonized particles with the various reagents alone did
not improvetheirpoor ingestibility nor did it preventsubsequent opsonization by
fresh serum. As shown in Table III, the paraffin oil plus Oil red 0 could be ex-
tracted from opsonized and washed particles with butanol. Radioactivity re-
mained associated with the LPS residue which, when re-emulsified in fresh
paraffin oil containing Oil red 0, yielded fully ingestible particles, indicating that
the C3 was bound to the LPS and not to the hydrocarbon. The table reveals that
treatment of the unopsonized particles with butanol did not alone render them
TABLE I
Effect of Various Treatments of the Bound C3 Radioactivity and Ingestibility of
Opsonized, Washed, BPS-Coated Paraffin Oil Particles
` The zero time values were determined using particles opsonized for 30 min and washed before
incubations with the indicated reagents. The zero time radioactivity was 10,700 cpm/ml of particle
suspension ; the particles were ingested at a rate of 0.226 mg paraffin oil/10' phagocytes/min.
$ The incubation wasterminated by addition of soybean trypsin inhibitor at afinal concentration of 1
mg/ml before washing.
Treatment
Time of
incubation
min
Radioactivity
% of value at
Ingestibility
zero time'
Modified KRPM 120 100 100
+ KAF, 50 kg/ml 120 74 75
+ Trypsin, 1 mg/ml$ 30 20 20
+ Phospholipase A, 200Aglml + 5 mM CaCl, 30 100 100
+ Phospholipase C, 200 gg/ml + 3 mM CaCl, 30 100 100
Fresh serum 120 54 55
+ 1 mM EDTA 120 55 50
+ 3 mM sodium m-periodate 120 66 Nottested
Heated serum 120 55 52
KAF-deficient serum 120 76 NottestedSTOSSEL, FIELD, GITLIN, ALPER, AND ROSEN
TABLE II
Effect of Various Treatments on Ingestibility andRadioactivity of
Opsonized, Washed, LPS-Coated Particles
* Control refers to radioactivity and ingestibility of opsonized, washed
particles not treated with any of the indicated reagents but with 0.13M
NaCl-15mM phosphate buffer, pH 7.4, for 60 min at 37°C . Boiling was
performed for 15 min in awaterbath .
$ Similar values were obtained when particles were exposed to 8M urea
dissolved in acetate, citrate, phosphate, or Tris-HCl buffers to providea
pH range of 3-11 or when 8 M urea was combined with 2 M NaCl or
with 6Mguanidine .
TABLE III
Effect ofSolventExtraction on theIngestibilityand Radioactivity of Opsonized, Washed,
LPS Particles
1335
LPS particles were treated with fresh or heated serum containing ["'I]C3, washed, boiled, extracted
with butanol, reconstituted from fresh buffer and paraffin oil Oil red O, anddivided into two portions .
One was treated with heated serum andthe other with freshserum (without added ["I]C3) . Rates of
uptake of the particles by human leukocytes and bound radioactivity were assayed .
ingestible nor did it interfere with their ability tobe opsonized with fresh serum .
Identical results were obtained from chloroform .
Table IV illustrates that some manipulations did impair ingestibility or
radioactivity of particles . Reactions of opsonized LPS-coated particles with
Treatment Radioactivity Ingestibility
% of control*
Boiling - + - +
Distilled water 100 100 100 100
2M NaCl 85 80 100 100
1 M glucose 98 95 100 100
0.5M MgCl, 96 85 100 95
8M urea$ 86 75 98 95
6Mguanidine 90 80 96 90
2% Triton X-100 79 75 88 85
0.2% Brij 35 85 80 97 94
2% deoxycholate 90 83 96 93
1% sodium decyl sulfate 90 80 95 90
1% 2-mercaptoethanol 94 79 100 99
Treatment after Rate of uptake
Initial treatment Radioactivity (mg paraffin oil/ reconstitution
10'phagocytes min)
cpm
Fresh serum Heated serum 1,498 0.108
Fresh serum Freshserum 1,427 0.124
Heated serum Heated serum 75 0.010
Heated serum Freshserum 57 0.1411336
￿
THE OPSONIC FRAGMENT OF C3
TABLE IV
Effect of Various Treatments on Ingestibility and Radioactiuity of
Opsonized, Washed, LPS Particles
* Radioactivity and ingestibility of opsonizedwashed particles treated with
0.13M NaCl-15mM phosphate buffer, pH 7.4, alone for60 min at 37°C .
anti-C3 F(ab') Z fragments markedly reduced ingestibility without altering
radioactivity . Alkylation of opsonized particles with iodoacetate decreased
ingestibility without diminishing radioactivity ; and, if reduction preceded
alkylation, the inhibitory effect was greater . The reducing agent alone had no
major effect on either radioactivity or ingestibility (Table 11) . Sodium dodecyl
sulfate at concentrations greater than 0.5% removed over 85% of the bound
radioactivity and abolished ingestibility of the opsonized particles .
The Structure of Opsonically Active C3 After Elution with Dodecyl
Sulfate. Since ingestibility and radioactivity of the particles withstood boiling
in 2 M NaCl solution followed by washing with distilled water, the opsonized
particles were treated in this way in order to remove as many loosely bound
proteins and salts as possible before elution with dodecyl sulfate . By extracting
the hydrocarbon from the particles with butanol and drying the LPS residue to
constant weight, it was determined that up to 2 .5 pg of C3 was bound/mg ofLPS,
assuming that the radioactive C3 was equivalent to the serum C3 in biologic
activity .
The radioactivity of dodecyl sulfate eluates of opsonized particles was soluble
in the detergent . Less than 25% of the radioactivity sedimented after ultrancen-
trifugation for 16 h at 500,000g or failed to traverse 0.2-pm pore Millipore filters .
However, the eluate became insoluble when the detergent was removed by
dialysis against 50% methanol or passage over a column ofDowexAG 1 x2, 200-
400 mesh (Dow Chemical Co ., Midland, Mich .) .
The dodecyl sulfate eluates of particles treated with fresh or heated (56°C, 30
min) serum were analyzed by electrophoresis on polyacrylamide gels (Fig . 2) .
Exposure of LPS-coated particles to fresh serum yielded different stainable
protein patterns in reduced eluates than exposure on heated serum . More bands
were resolved in eluates of particles incubated in fresh serum which migrated
with mobilities corresponding to mol wt greater than 100,000 . A major difference
between eluates of opsonized particles and particles treated with heated serum
was the appearance of a Coomassie Blue stainable band in reduced eluates of
opsonized particles which had a mobility consistent with a mol wt of approxi-
Treatment Radioactivity
of
Ingestibility
control*
Anti-C3 (Fab'), 100 15
5 x 10-5M iodoacetate
without prior reduction 100 45
with priorreduction 100 20
1% Sodium dodecyl sulfate 10 5STOSSEL, FIELD, GITLIN, ALPER, AND ROSEN
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FIG . 2.
￿
Electrophoresis of LPS-coated particle eluates on polyacrylamide gels with dodecyl
sulfate . A reduced eluate from LPS-coated particles treated with heated serumwas applied to
the top gel . A reduced eluate from LPS-coated particles treated with fresh serum was applied
to the lower gel, and thegraph depicts "'I radioactivity of that gel (-) andof a gel to which
unreduced eluate from LPS-coated particles treated with fresh serum was applied (---) . The
radioactive peak in the reduced eluate corresponds with the stained band directly above the
radioactive peak . The molecular weights of the radioactive peaks are indicated . An eluate of
particles incubated with buffer rather than serum yielded no stainable protein after
electrophoresis .
mately 70,000 and which constituted up to 10% of the total stainable protein.
Almost all of the radioactivity of reduced eluates prepared from particles
incubated in fresh serum with [1251]C3 was invariably found within this band in
spite of some variation in the stainable protein profile of nonradioactive bands
from one preparation to another. The radioactive band did not stain with PAS.
Particles incubated with heat serum containing [1251]C3 contained negligible
radioactivity after preparation for elution, and the eluates contained only traces
of the 70,000 mol wt band . In unreduced eluates of opsonized particles, the 70,000
mol wt peptide did not appear . Instead, a radioactive peak migrated with a
mobility corresponding to a mol wt of 140,000 . However, considerable radioactiv-
ity remained at the origin of these gels . If particles incubated in fresh serum were
washed in isotonic buffers before elution instead of first being boiled and washed
with 2MNaCl, radioactive peaks were found in the reduced eluates with mol wt
of 115,000 and 30,000, as well as the major 70,000 mol wt band .
Less than 20% of [1"C]LPS eluted with 1251-labeled protein in dodecyl sulfate.
The 1 'C migrated much more rapidly than the 1251 on the polyacrylamide gels
(Fig . 3) . Dodecyl sulfate eluates of HSA-coated paraffin oil particles which were
opsonized with fresh serum containing [1251]C3, washed with 2 M NaCl, and
extracted with butanol had a stainable peptide of mol wt 70,000 when reduced1338
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FIG. 3 .
￿
Electrophoresis of areducedLPS-coated particle eluate on a polyacrylamide gel with
dodecyl sulfate .The eluate wasprepared from ["C]-LPS-coated particles opsonized with fresh
serum containing ["'I]C3 . The graph depicts the absorbance of Coomassie Blue-stained
protein (-) . "5I radioactivity ( . . .), and "C radioactivity (---) .
and subjected to electrophoresis on polyacrylamide gels . All radioactivity
migrated in the region of this band .
Immunochemical Reactivity of Opsonized Particles . Opsonized, washed
particles boiled in 2 M NaCl and injected repeatedly into rabbits elicited
antibodies strongly reactive against C3 in human serum (Fig . 4) . Weak reactions
with IgG and IgM were detectable . The antiserum reacted against the immuno-
chemically defined C3 fragments, C3b and C3c, but not against C3d (Fig . 5) .
Conversely, undiluted anti-C3 antiserum but not anti-C3d antiserum ag-
glutinated opsonized, washed LPS-coated particles boiled in 2 M NaCl .
Although anti-C3 F(ab')2 fragments blocked the ingestibility of opsonized,
washed LPS-coated particles boiled with 2M NaCl, anti-C3d F(ab') 2 fragments
did not have this effect . However, if the opsonized, washed particles were not
boiled with 2M NaCl, anti-C3d F(ab') 2 fragments did have an inhibitory action
(Table V) .
Subunit Structure of C3 : Correlation with Opsonically Active C3 .
￿
Purified
C3, homogeneous by immunochemical and electrophoretic criteria, eluted from
an agarose column in a position corresponding to a globular protein of mol wt
180,000 . It could be resolved into subunits by vigorous denaturation and
reduction . Scission of the molecule into its constituents was reliably achieved by
boiling for 15 min in 1% dodecyl sulfate with 50 mM dithiothreitol or 1% 2-
mercaptoethanol . The major peptides of C3 when analyzed by electrophoresis
on polyacrylamide gels or chromatography on Sephadex G-100 with dodecyl
sulfate had mol wt of 115,000 and 70,000, respectively (Fig . 6) . However,
additional peptides with mol wt of 80,000 and 35,000 were present in variable
amounts and eluted with the 70,000 mol wt peptide during chromatography . A
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FIG . 4.
￿
Reactions of rabbit antiserum to opsonized, washed, LPS-coated particles boiled in 2
M NaCl (upper trough) against purified C3 (1) and whole serum (2), after electrophoresis in
agar gel . Rabbit antiserum to wholehuman serum was in the lower trough .
FIG. 5.
￿
Reactions of rabbit antiserum to opsonized, washed, LPS-coated particles boiled in 2
MNaCl (center well) against purified C3 and its conversion products, C3b, C3c, and Cad, by
double diffusion in agar gel .
number of findings indicated that the 80,000 mol wt peptide is a fragment of the
115,000 mol wt subunit of C3 . Tryptic peptides of the 80,000 mol wt band after
elution from the polyacrylamide gels corresponded to tryptic peptides found in
the 115,000mol wt subunit purified either by elution from polyacrylamide gels or1340 THE OPSONICFRAGMENT OF C3
TABLE V
Effect of Anti-C3d on the Ingestibility of Opsonized, Washed,
LPS-coated Paraffin Oil Particles by Human Peripheral Blood
Phagccytes : Influence of Boiling the Particles with 2MNaCl
Notboiled
with
2M NaCl
Rate of ingestion
(mgparaffin oil/10'
phagocytes/min)
Boiled with
2M NaCl
Control
￿
0.21
￿
0.20
Anti-C3d
￿
0.04
￿
0.19
Opsonized, washed, LPS-coated particles were divided into two portions,
one of which was boiled with 2 M NaCl . Boiled and unboiled particles
were reacted with heated (56°C, 30 min) goat serum (control) or else goat
antihuman C3d antiserum for60 min at 25°C, washed with albumin solu-
tion, and assayed for ingestibility by human blood phagocytes .
FIG . 6.
￿
Chromatography of purified, reduced, denatured C3 + ["SIjC3 on Sephadex G-100 .
The elution profile of ...I is indicated . The polyacrylamide gels were prepared from thepooled
radioactive peaks, andthe molecular weights of the stainable peptides are indicated .
chromatography on Sephadex G-100 with dodecyl sulfate. Furthermore, when
the areas under the 80,000 and 35,000 mol wt peaks were added to that of the
115,000 component on densitometric scans of stained polyacrylamide gels, total
areas accounted for an equimolar amount of protein relative to the 70,000 mol wt
peptide. Some of the tryptic peptides of the 70,000 mol wt component comigrated
with those of the 115,000 subunit, both as determined by ninhydrin staining or
autoradiography of 1251-labeled peptides. However, as shown in Fig . 7, the
115,000 and 70,000 mol wt chains did have distinct peptides . The findings suggestSTOSSEL, FIELD, GITLIN, ALPER, AND ROSEN
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CHROMATOGRAPHY
Discussion
ELECTROPHORESIS
FIG . 7 .
￿
Composite tryptic peptidemap autoradiogram indicating radioactive peptides found
only in the isolated 115,000 mol wt component of C3 (open spots), spots found only in the
isolated 70,000 mol wt subunit of C3 (enclosed by dotted circles) .
that C3 has 115,000 and 70,000 mol wt subunits but that theheavier peptide chain
undergoes some decomposition during the vigorous denaturation required for
separation of the C3 subunits .
Tryptic peptide map autoradiograms of the 70,000 mol wt radioactive band
eluted from polyacrylamide gels to which dodecyl sulfate eluates of opsonized
LPS-coated particles were applied revealed spots corresponding to all of the
distinct radioactive peptides of the 70,000 mol wt chain of C3 and to some of the
distinct radioactive peptides of the 115,000 mol wt chain (Fig . 7) . Opsonically
active C3 is, therefore, composed of the 70,000 mol wt subunit of C3 and a70,000
mol wt fragment of the heavy chain .
The Opsonically Active Fragment of C3 .
￿
Considerable evidence points to a
form of bound C3 as an agent that elicits recognition by phagocytic cells.
Erythrocytes or pneumococci coated sequentially with antibody and classic C
components C1, C4, and C2 become opsonized only when C3 is added .
Subsequent proteins of the C system have little or no influence on opsonic
expression (2-4) . Fresh serum opsonized LPS- or HSA-coated paraffin oil
particles by reactions involving the properdin system alone . C3-deficient serum
has no opsonic activity for these particles, and addition of C3 to the deficient
serum restores opsonic activity in proportion to the quantity ofC3 added (9, 10) .
During opsonization of particles by either classic or properdin pathways, C3
becomes fixed to the particle surface (3, 9, 10) . Anti-C3 F(ab') 2 fragments block
the opsonic expression of C3 bound either to erythrocytes by antibody and the
classic pathway (36) or, as demonstrated in this report, LPS-coated paraffin oil
particles opsonized by the properdin pathway . Although proteins other than C3
become attached to LPS-coated particles and to membranes of antibody-coated1342
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erythrocytes during incubation in fresh serum (37, 38), it appears to be C3 in its
activated and bound form that affords opsonic expression .
Binding and Stability of C3 on Opsonized Particles . Early studies with
bacteria suggested moderate thermal and physical stability of the opsonized
state, but the fragility of the test particles precluded adequate functional
analysis (39, 40) . An investigation of [' 251]C3 bound to erythrocyte membranes
revealed firm binding of the radioactive C3, although opsonic function of the
bound protein was not assayed (41) .
The experiments described in this report demonstrated that C3 is strongly
bound to HSA- and LPS-coated paraffin oil or fluorochemical liquid particles
and that its opsonic expression is strikingly resistant to physical and chemical
perturbation . Bound radioactivity and opsonic expression withstood treatment
with extremes of pH, temperature, and ionic strength, organic solvents, and a
number of strong protein perturbants . Only the detergent sodium dodecyl sulfate
efficiently removed radioactivity . A closely related detergent, sodium decyl
sulfate, was ineffective . From these facts in can be inferred that C3 is attached to
the LPS by a hydrophobic bond . It is possible, however, that this linkage is
complex and that the dodecyl sulfate acts on neighboring molecules, as well ason
the binding site to effect removal . The possibility that C3 is covalently bound to
the LPS and that dodecyl sulfate removes a peripheral LPS-C3 complex is
unlikely because [''C]LPS did not comigrate with ['ZSI]C3 when subjected to
electrophoresis on polyacrylamide gels in dodecyl sulfate . That the opsonic
fragment of C3 might be covalently bound to protein in the LPS is also
improbable, since the molecular weight of the eluted, reduced radioactive
fragment was the same whether LPS-coated or HSA-coated particles were
employed .
Serum also removed C3 radioactivity and opsonic expression from particles.
This serum activity was heat resistant, did not require divalent cations, and was
diminished in KAF-deficient or sodium metaperiodate-treated sera. The serum
activity is, therefore, partly attributable to the presence of KAF, which is
sensitive to sodium metaperiodate but not to heat or EDTA (13) .
Structure of Opsonically Active C3 .
￿
Opsonic expressions of C3 was resistant
to phospholipases A and C and to organic solvents suggesting that it is not a
lipoprotein . The eluted polypeptide was PAS negative, consistent with a lack of
abundant carbohydrate . The sensitivity of opsonic expression to alkylation and
greater sensitivity to reduction followed by alkylation indicate the influence of
both sulfhydryl and disulfide groups on the function of the molecule . The
presence of inter- and intrachain disulfide bridges could explain the remarkable
stability of particle-bound C3, the covalent bonds protecting the molecular
structure from thermal and chemical denaturation .
The stability of C3 facilitated analysis of its structure . By vigorous washing of
opsonized particles, including boiling with 2M NaCl, irrelevant peptides derived
from C3 and other proteins could be removed . After such treatment, elution of
opsonized particles with sodium dodecyl sulfate and a reducing agent yielded a
70,000 mol wt radioactive polypeptide or a 140,000 mol wt protein in the absence
of the reducing agent . The findings suggested the opsonically active moiety of
C3 has a mol wt of 140,000 and is composed oftwo 70,000 mol wt subunits linkedSTOSSEL, FIELD, GITLIN, ALPER, AND ROSEN
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by disulfide bonds . Comparison of this molecule with the subunit composition
of C3 revealed the origin of the opsonically active molecule .
During gel filtration of C3 in a nondenaturing solvent and at high ionic
strength to prevent adsorption, C3 eluted as a globular protein with a mol wt of
approximately 180,000 . This value is in agreement with estimates based on other
techniques (29) . Nilsson and Mapes reported that reduced and denatured C3
could be resolved into 110,000 and 70,000 mol wt subunits (42) . Our findings are
in general agreement with this formulation although complicated by the fact that
other polypeptides, possibly representing partial degradation of the major
subunits, were invariably observed . Tryptic peptide mapping and densitometric
analysis of C3 fragments resolved by reduction, denaturation, and electrophore-
sis on polyacrylamide gels with dodecyl sulfate suggested that the isolated 70,000
mol wt polypeptide was contaminated by variable amounts ofthe 115,000 mol wt
component . Nevertheless, the tryptic maps showed that the isolated 70,000 mol
wt polypeptide was sufficiently distinct from the 115,000 mol wt chain to permit
the conclusion that one of the 70,000 mol wt subunits of opsonically active C3
was, in fact, the 70,000 mol wt piece ofC3 . The presence of tryptic peptides from
the 115,000 mol wt component in opsonically active C3 indicated that a fragment
of 115,000 mol wt chain also comprises the opsonically active molecule .
If the opsonically active portion of C3 has a mol wt of 140,000, then a 45,000
mol wt fragment or fragments must be broken from C3 during opsonization . In
fact, a 30,000 mol wt radioactive fragment was found in eluates of particles not
boiled in 2 M NaCl . This finding suggests that the 30,000 mol wt fragment, or
16% of C3, is removed by 2M NaCl . Particles treated with 2M NaCl lost 15-20%
of their 1261 radioactivity but little or no ingestibility, a discrimination possible
because of the quantitative resolution of the ingestion assay .
C3 attacked briefly by C142 or by trypsin is cleaved into two fragments, C3a
and C3b . Since C3a is a small peptide at the amino terminal of the 115,000 mol
wt chain of C3, C3b would have to be almost as large a molecule as C3 (29) . C3
attacked by more prolonged incubation with trypsin or aged in serum yields at
least two electrophoretically distinct fragments, C3c and C3d, estimated to have
mol wt of 150,000 and 27,000, respectively (16,20) . However, the structure of
these fragments is not precisely understood . Recent studies have shown that C3b
is cleaved by KAF . This enzyme, which allows bovine serum to conglutinate
bound C3, rapidly cleaves the 110,000 mol wt chain of C3b to a smaller size of
85,000 mol wt (19) . The molecule, after KAF action, then has an intact
polypeptide chain of 70,000 mol wt and another of 85,000 mol wt . It has been
designated C3b' to indicate that the enzymatic property of C3b to activate the
properdin system has been inactivated . C3b' is exquisitely sensitive not only to
further KAF action but to a variety of proteolytic enzymes such as trypsin to
which C3b is relatively resistant . These agents cleave the 85,000 mol wt chain
down to a mol wt of 70,000 . Neither the first cleavage product, which has a mol wt
of about 25,000, nor the second cleavage product, which as a mol wt of about
15,000, has been well characterized . Furthermore, it is not known which of these
fragments is C3d .
Antisera to some of these C3 fragments reacted differently with opsonized,
washed, LPS-coated particles depending on whether the particles were washed1344
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with 2 M NaCl . The ingestibility of all opsonized particles was inhibited by
anti-C3 F(ab') 2 fragments. Anti-C3d F(ab') 2 only inhibited uptake of opsonized
particles not boiled with 2M NaCl ; they did not inhibit ingestion of opsonized
particles treated with 2M NaCl . Conversely, opsonized, washed particles boiled
in 2M NaCl elicited antibodies that reacted with C3, C3b, and C3c but not with
C3d. The results suggest that the fragment which is removed from the opsonized
particles with 2MNaCl is similar not only in molecular size but in antigenicity
to C3d and is not relevant for opsonic expression . All of the immunochemical and
chemical observations show that the entity defined as C3b itself is not the
opsonically active fragment, although all of its parts may be bound to particles
during opsonization .
Eryfbrocytes sensitized with C3b are not ingested (18) . KAF treatment of
EAC1423b cells results in the release of C3c into the fluid phase with continued
binding of C3d on the erythrocyte membrane (15,18) . This observation has been
taken by some as indirect evidence for opsonic activity of C3b . It was concluded
that C3b was constituted only of C3c and C3d and that release ofC3c resulted in
the loss of the opsonic effector site, whereas C3d contained the erythrocyte-bind-
ing site . Evidence presented in this paper showed that C3d is irrelevant to the
opsonic process and that C3d could be removed without concomitant loss of
opsonic activity . The complexity of the interaction between KAF and C3b
precludes simple conclusions concerning binding and effector sites under the
conditions of previously reported experiments. It is possible that the conglutina-
ble form of C3, namely C3b`, is also theopsonically active moiety of the molecule .
Summary
Human peripheral blood phagocytes ingest Escherichia coli 026:B6 lipopoly-
saccharide (LPS)-coated paraffin oil droplets containing Oil red O only if fresh
serum deposits C3 on the surfaces of the particles (opsonizes them), by reactions
involving the properdin system . The rate of binding of purified ['z5I]C3 in serum
to LPS-coated particles correlated precisely with the rate of acquisition of
ingestibility assayed spectrophotometrically . Once opsonized, LPS-coated parti-
cles remained fully ingestible and retained fixed [I "I ]C3 radioactivity even after
exposure to extremes of temperature, pH, ionic strength, phospholipases, urea or
guanidine, some nonionic and ionic detergents, and organic solvents . Trypsin,
human conglutinogen-activating factor, another heat-stable activity found in
human serum, and sodium dodecyl sulfate removed radioactivity and diminished
ingestibility of the opsonized particles. Alkylation, reduction plus alkylation
and F(ab') 2 from anti-C3 blocked ingestibility but did not alter particle-bound
radioactivity .
Electrophoretic and tryptic peptide autoradiographic analysis of dodecyl
sulfate eluates of opsonized particles, cleansed of many contaminating proteins
by boiling with 2M NaCl (yet still opsonized), revealed that the polypeptide with
C3-derived radioactivity had a mol wt of approximately 140,000 and was
composed of 70,000 mol wt subunits linked by disulfide bonds . Immunochemical
analysis and comparison of the peptide structure of the eluate with that of C3indicated that the opsonic fragment is not the fragment defined as C3b but a
smaller derivative of C3 .
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